Download presentation
Presentation is loading. Please wait.
Published byΔιονύσιος Αλιβιζάτος Modified over 5 years ago
1
Different small-dose sufentanil blunting cardiovascular responses to laryngoscopy and intubation in children: a randomized, double-blind comparison† F.S. Xue, Y.C. Xu, Y. Liu, Q.Y. Yang, X. Liao, H.P. Liu, Y.M. Zhang, J.H. Liu, M.P. Luo British Journal of Anaesthesia Volume 100, Issue 5, Pages (May 2008) DOI: /bja/aen032 Copyright © 2008 British Journal of Anaesthesia Terms and Conditions
2
Fig 1 The per cent changes of systolic blood pressure (SBP) during the observation in the four groups. Children in Groups 1, 2, 3, and 4 received normal saline, sufentanil 0.1 μg kg−1, sufentanil 0.2 μg kg−1, and sufentanil 0.3 μg kg−1, respectively. Points were means. *P < 0.05 compared with Group 1, #P < 0.05 compared with Group 2, †P < 0.05 compared with Group 3. British Journal of Anaesthesia , DOI: ( /bja/aen032) Copyright © 2008 British Journal of Anaesthesia Terms and Conditions
3
Fig 2 The per cent changes of heart rate (HR) during the observation in the four groups. Children in Groups 1, 2, 3, and 4 received normal saline, sufentanil 0.1 μg kg−1, sufentanil 0.2 μg kg−1, and sufentanil 0.3 μg kg−1, respectively. Points were means. *P < 0.05 compared with Group 1, #P < 0.05 compared with Group 2, †P < 0.05 compared with Group 3. British Journal of Anaesthesia , DOI: ( /bja/aen032) Copyright © 2008 British Journal of Anaesthesia Terms and Conditions
4
Fig 3 The incidences of SBP and HR per cent changes >30% of baseline values during the observation in the four groups. Children in Groups 1, 2, 3, and 4 received normal saline, sufentanil 0.1 μg kg−1, sufentanil 0.2 μg kg−1, and sufentanil 0.3 μg kg−1, respectively. Note: the incidences of SBP and HR per cent increases >30% of baseline values during the observation in Group 4 were 0%. *P < 0.05 compared with Group 1; #P < 0.05 compared with Group 2. British Journal of Anaesthesia , DOI: ( /bja/aen032) Copyright © 2008 British Journal of Anaesthesia Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.